CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Data – The Foundation of Clinical Trials

The life sciences industry has been fundamentally altered

in recent years. Diseases that were once considered

life-threatening and terminal are now being managed as

chronic conditions. Previous chronic illnesses are treatable

and curable, while other diseases have been reduced to

irritations or consigned to the history books. Richard Young,

Vice-President, EDC, Veeva Systems, discusses how a

changing world brings data to the forefront, but how do

we manage it all to make the biggest impact.

https://international-pharma.com/wp-content/uploads/2017/04/Data.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026